Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2003
12/18/2003WO2003104441A2 Novel bacterial strain, compositions derived therefrom and methods of using same for treating beta-ap-associated deseases
12/18/2003WO2003104438A2 Cancer-linked gene as target for chemotherapy
12/18/2003WO2003104437A2 Anti-addl antibodies and uses thereof
12/18/2003WO2003104436A2 Cancer-linked gene as target for chemotherapy
12/18/2003WO2003104435A2 Cancer-linked gene as target for chemotherapy
12/18/2003WO2003104434A2 A method to amplify variable sequences without imposing primer sequences
12/18/2003WO2003104431A2 Transgenic mammals expressing polyglutamine
12/18/2003WO2003104430A2 Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes
12/18/2003WO2003104429A2 Genes overexpressed by ovarian cancer and their use in developing novel therapeutics
12/18/2003WO2003104428A2 Gene differentially expressed in breast and bladder cancer and encoded polypeptides
12/18/2003WO2003104427A2 Methods and compositions for detecting cancers
12/18/2003WO2003104426A2 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof
12/18/2003WO2003104419A2 Cancer-linked gene as target for chemotherapy
12/18/2003WO2003104415A2 Method to screen ligands using eukaryotic cell display
12/18/2003WO2003104414A2 Artificial transcription factors
12/18/2003WO2003104412A2 Spliceosome mediated rna trans-splicing and correction of factor viii genetic defects using spliceosome mediated rna trans spling
12/18/2003WO2003104410A2 Enzymes
12/18/2003WO2003104407A2 T cell receptor cdr3 sequences and methods for detection
12/18/2003WO2003104404A2 Cancer-linked gene as target for chemotherapy
12/18/2003WO2003104401A2 Cancer-linked gene as target for chemotherapy
12/18/2003WO2003104400A2 Secretory signal sequences and uses thereof
12/18/2003WO2003104399A2 Cancer-linked gene as target for chemotherapy
12/18/2003WO2003104395A2 Receptors and membrane-associated proteins
12/18/2003WO2003104392A2 Improved reagents and methods for producing parvoviruses
12/18/2003WO2003104391A2 Antibacterial targets in alloiococcus otitidis
12/18/2003WO2003104381A2 Methods
12/18/2003WO2003104282A2 Immunoadhesin comprising a glycoprotein vi domain
12/18/2003WO2003104279A1 Regulation of a human g protein-coupled receptor
12/18/2003WO2003104278A1 Tnf-like protein
12/18/2003WO2003104277A2 Stat6 activation gene
12/18/2003WO2003104276A2 Genes and polypeptides relating to hepatocellular or colorectal carcinoma
12/18/2003WO2003104275A2 Genes and polypeptides relating to human colon cancers
12/18/2003WO2003104274A1 Scorpion peptide as hypotensive agent
12/18/2003WO2003104273A2 Therapeutic epitopes and uses thereof
12/18/2003WO2003104272A1 Immunogenic compositions
12/18/2003WO2003104271A1 Enzymes which degrade thio compounds, and methods of use thereof
12/18/2003WO2003104270A2 Dudulin 2 genes, expression products, non-human animal model: uses in human hematological disease
12/18/2003WO2003104268A1 Par-2-activating peptide derivative and pharmaceutical composition using the same
12/18/2003WO2003104264A1 Protein purification from transgenic avian eggs
12/18/2003WO2003104263A2 Cytokines and cytokine receptors with reduced immunogenicity
12/18/2003WO2003104262A2 Gp41 peptides and methods based-thereon for inhibiting hiv fusion to target cells
12/18/2003WO2003104261A2 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto
12/18/2003WO2003104259A2 PEPTIDES PRESENTED BY HLA-B18 AND Cw16 MOLECULES, AND USES THEREOF
12/18/2003WO2003104258A2 Dominant gene delaying flowering
12/18/2003WO2003104243A1 Chemical synthesis of reagents for peptide coupling
12/18/2003WO2003103725A1 Compositions and methods for the diagnosis and treatment of tumor
12/18/2003WO2003103720A2 Compositions and methods for the use of bcl-2 transfected neurons
12/18/2003WO2003103719A2 Method for triggering apoptosis in cells by increasing the level of c1d and inhibiting the degradation of the same
12/18/2003WO2003103715A1 Modified byrodin 1 with reduced immunogenicity
12/18/2003WO2003103705A1 Metalloproteinase inhibitors
12/18/2003WO2003103702A1 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
12/18/2003WO2003103698A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
12/18/2003WO2003103697A2 Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity
12/18/2003WO2003103662A2 Inhibitors of glycoprotein vi
12/18/2003WO2003103608A2 Neuroprotective synergy of erythropoietin and insulin-like growth factor
12/18/2003WO2003103606A2 Methods and compositions for treating and diagnosing diabetes
12/18/2003WO2003103605A2 Flexible vaccine assembly and vaccine delivery platform
12/18/2003WO2003103601A2 Methods of diagnosing & treating diabetes and insulin resistance
12/18/2003WO2003103595A2 Androgen receptor coregulators
12/18/2003WO2003103592A2 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use
12/18/2003WO2003103589A2 Use of il-21 in cancer and other therapeutic applications
12/18/2003WO2003103588A2 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer
12/18/2003WO2003103581A2 Compositions and methods for liver growth and liver protection
12/18/2003WO2003103577A2 Novel recombinant anticoagulant proteins
12/18/2003WO2003103572A2 Modified glucagon-like peptide-1 analogs
12/18/2003WO2003103571A2 Flavivirus vaccines
12/18/2003WO2003103570A2 Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles
12/18/2003WO2003103475A2 Prevention and reduction of blood loss
12/18/2003WO2003084995A3 Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof
12/18/2003WO2003082912A3 Transgenic plants expressing mussel adhesive proteins
12/18/2003WO2003082897A3 Synthetic active peptide fragments
12/18/2003WO2003080660A3 Method for the preparation of recombinant mammalian heparin-binding protein (hbp)
12/18/2003WO2003074692A3 Specific gene expression in colonic cancer cell lines
12/18/2003WO2003074673A3 Lgals as modifiers of the chk pathway and methods of use
12/18/2003WO2003074558A3 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
12/18/2003WO2003074549A3 Assay for anti-ingap antibodies
12/18/2003WO2003070271A3 Novel complexes for inducing an immune response
12/18/2003WO2003068930A3 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
12/18/2003WO2003058248A3 Diagnostics and vaccines for mycrobacterium paratuberculosis infections
12/18/2003WO2003057911A3 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
12/18/2003WO2003054167A3 Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
12/18/2003WO2003054160A3 Cell lines with latent immunodeficiency virus and methods of use thereof
12/18/2003WO2003052378A3 Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1
12/18/2003WO2003051917A3 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
12/18/2003WO2003046179A3 G-protein coupled receptor lustr2 and uses thereof
12/18/2003WO2003046131A3 Dnmt3l-related cloning and reproductive methods
12/18/2003WO2003044047A3 Virulence proteins of the genus yersinia and uses thereof
12/18/2003WO2003042655A3 Diagnostic assay for antibiotic tolerance
12/18/2003WO2003040726A3 Screening for hepatitis c virus entry inhibitors
12/18/2003WO2003040309A3 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
12/18/2003WO2003039477A9 Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding
12/18/2003WO2003037164A3 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
12/18/2003WO2003030885A3 Modulation of the adventitial tool-like receptor
12/18/2003WO2003029437A3 Secreted proteins
12/18/2003WO2003029414A3 INTRODUCTION OF THE WLDs GENE FOR PREVENTION OF AXONAL DEGENERATION IN NEUROLOGICAL DISEASES
12/18/2003WO2003018810A3 Modified cry3a toxins and nucleic acid sequences coding therefor
12/18/2003WO2003018625A3 Allelic variants of herv-k18 provirus and their use in analysis
12/18/2003WO2003006619A3 Calcineurin modulators
12/18/2003WO2003006045A3 Cxcl10 treatment of secondary tissue degeneration
12/18/2003WO2003004684A9 NUCLEIC ACIDS ENCODING A RECOMBINANT 250 kDa ANTIGEN FROM SPOROZOITES/MEROZOITES OF EIMERIA MAXIMA AND THEIR USES
1 ... 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 ... 2916